Navigation Links
MUHC announces a transplant first in Quebec

Doctors at the MUHC have announced Quebec's first successful combined heart/liver transplant. The patient, Patrice Dionne, age 54 years, was transferred from the Institut de cardiologie de Quebec (l'hôpital Laval) to the MUHC. The patient received his new heart and liver during a 6-hour operation on April 14, 2006 and was discharged 10 days later. The complex procedure involved 15 physicians, surgeons and other health care professionals. The MUHC conducts the most organ transplants in Quebec and has the most comprehensive multi-organ transplant program in the province.

"Combined heart/liver transplants are so rare that the best technique for a combined implantation has not yet been elucidated," says Dr. Kevin Lachapelle, a Cardiac Surgeon at the MUHC, who performed the combined procedure with Dr. Peter Metrakos (Liver Surgeon). "Historically these procedures are done separately, but because both organs were procured from Quebec City at the same time by MUHC Drs. Ergina and Paraskevas and because sequential transplants can have a profound negative effect on the heart, we decided a simultaneous implantation offered the best hope of success."

The patient, Patrice Dionne, who was referred to the Institut de cardiologie de Quebec for medical evaluation for a possible heart transplant, was transferred to the MUHC after liver complications necessitated a complex multi-organ transplant. "The patient had waited three years for a heart transplant, during which time his liver began to deteriorate," says Dr. Bernard Cantin, Director of Heart Transplantation at the Institut de cardiologie de Quebec. "At this point we knew the MUHC was the only hospital where we could transfer our patient for this lifesaving surgery." The speed and ease at which this patient transfer occurred demonstrates the level of collaboration and teamwork that exists between hospitals within Quebec.

"The patient made a rapid recovery after surgery, and was discharged after only 10 da ys," says Dr. Nadia Gianetti, Medical Director the Heart Failure and Heart Transplant Program at the MUHC. "The seamless collaboration between the cardiac and liver transplant teams at the MUHC is one of many reasons why the planning, surgery, and follow-up care of Mr. Dionne was so straightforward and uncomplicated." The patient has now fully recovered and is again living a full and rich life. "I am extremely impressed with the doctors at the MUHC; from the onset I had unquestioned confidence in their ability to perform this complex surgery," says Patrice Dionne. "I'm so thankful that I will now be able to enjoy this fathers day with my three sons."

"As a comprehensive Multi-Organ Transplant Program, we are accustomed to collaborating with other institutions across Quebec and other provinces for this form of highly specialized patient care," says Dr. Renzo Cecere, Surgical Director of Heart Failure and Heart Transplantation at the MUHC. "We are particularly pleased to have specialists from every discipline with a strong interest in transplantation, allowing us to successfully offer combined organ transplants within one institution."

The world's first heart transplant was conducted less than forty years ago; complex combined transplants have only been conducted since the 1980's. Multi-organ transplants, such as the combined heart-liver transplant conducted at the MUHC require a multi-specialized team, consisting of cardiologists, hepatologists, intensive care specialists, anesthesiologists, nurses, physiotherapists and Transplant Quebec coordinators. Combined heart-liver transplants are rare--only a few successful procedures have been performed in Canada, and this is the first in Quebec.


'"/>

Source:McGill University


Related biology news :

1. Wiley announces publication of Databasing the Brain
2. Nonlinear Dynamics announces more details of its global partnership with PerkinElmer
3. Neurologix announces positive results of gene therapy clinical trial in Parkinsons disease
4. Eisai announces Phase II data on E7389, a potential new therapy for the treatment of breast cancer
5. GlycoFi announces the first production of antibodies with human glycosylation in yeast
6. NHGRI announces new sequencing targets
7. CHAVI announces international search for genes affecting HIV response
8. NHGRI announces latest sequencing targets
9. St. Jude announces breakthrough in eye cancer treatment
10. NIH announces phase III clinical trial of creatine for Parkinsons disease
11. Discoveries by UAB and Florida scientists may help transplanted organs survive longer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
(Date:3/21/2016)... Unique technology combines v ... security   Xura, Inc. ... digital communications services, today announced it is working alongside ... customers, particularly those in the Financial Services Sector, the ... within a mobile app, alongside, and in combination with, ...
(Date:3/15/2016)... March 15, 2016 Yissum Research Development ... technology-transfer company of the Hebrew University, announced today the ... sensing technology of various human biological indicators. Neteera Technologies ... million from private investors. ... the detection of electromagnetic emissions from sweat ducts, enables ...
Breaking Biology News(10 mins):
(Date:4/27/2016)... , April 27, 2016 ... (CSE: NSK) (OTCPink: NSKQB) ( Frankfurt ... an ihre Pressemitteilung vom 13. August 2015 die ... ihre Finanzen um zusätzliche 200.000.000 Einheiten auf 400.000.000 ... Dollar zu bringen. Davon wurden 157.900.000 Einheiten mit ...
(Date:4/27/2016)... Virgin Islands (PRWEB) , ... April 27, 2016 ... ... Company Ltd. (d/b/a Biohaven) is pleased to announce the appointment of John Tilton as ... was an Executive Director and one of the founding commercial leaders responsible for ...
(Date:4/27/2016)... ... April 27, 2016 , ... PathSensors, Inc., ... Advisory Board. Dr. Lamka will assist PathSensors in expanding the use of the ... deploys the CANARY® test platform for the detection of harmful pathogens, including a ...
(Date:4/27/2016)... ... 2016 , ... Global Stem Cells Group CEO Benito Novas announced ... of GSCG affiliate Kimera Labs in Miami. , In 2004, Ross received his Ph.D. ... for hematologic disorders and the suppression of graft vs. host disease (GVHD) under UM ...
Breaking Biology Technology: